These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14947620)

  • 61. [The detoxifying action of periston N in toxemic tuberculotics].
    ALIOTTA N; CATASTA L; SAMPERISI F
    Clin Nuova Rass Prog Med Int; 1954 Aug 14-28; 19(15-16):83-8. PubMed ID: 13219753
    [No Abstract]   [Full Text] [Related]  

  • 62. [Electron microscopic studies on the morphology of the uptake of macromolecular substances (dextran, periston) in the spleen].
    GABLER G; JUNG F
    Acta Biol Med Ger; 1960; 4():492-500. PubMed ID: 13702782
    [No Abstract]   [Full Text] [Related]  

  • 63. [Periston-N-infusions in icteric newborn infants].
    HALFPAP E; NATALIS H
    Zentralbl Gynakol; 1955; 77(37):1465-8. PubMed ID: 13275100
    [No Abstract]   [Full Text] [Related]  

  • 64. [On the therapy of icterus neonatorum in premature infants with kollidon infusions (periston N)].
    DIECKHOFF J; THEILE L; THEILE H
    Z Kinderheilkd; 1959; 82():539-47. PubMed ID: 13816643
    [No Abstract]   [Full Text] [Related]  

  • 65. [Effects of kallikrein and periston on hypoglycemic convulsions in mice].
    OSSWALD H
    Z Gesamte Exp Med; 1955; 126(3):208-13. PubMed ID: 13300281
    [No Abstract]   [Full Text] [Related]  

  • 66. [Subtosan, a preparation that fills a need].
    ABIRACHED IA
    Rev Bras Cir; 1949 Sep; 18(9):607. PubMed ID: 18149257
    [No Abstract]   [Full Text] [Related]  

  • 67. [Severe thrombopenic purpura caused by neosalvarsan appearing with signs of Werlhof's disease treated with periston N].
    JUNG HD
    Hautarzt; 1955 Sep; 6(9):412-4. PubMed ID: 13277933
    [No Abstract]   [Full Text] [Related]  

  • 68. [Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone].
    JATZKEWITZ H
    Hoppe Seylers Z Physiol Chem; 1954; 297(3-6):149-56. PubMed ID: 13221275
    [No Abstract]   [Full Text] [Related]  

  • 69. [On the transformation of chondriome by accumulation of macromolecular substances (dextran, periston). Electron microscopic investigations on the reticuloendothelium of the rat spleen].
    GABLER G
    Virchows Arch Pathol Anat Physiol Klin Med; 1960; 333():230-40. PubMed ID: 13702786
    [No Abstract]   [Full Text] [Related]  

  • 70. [The 25o / o subtosan, effective delay vehicle].
    PERRAULT M
    Hopital; 1947 Aug; 35(553):167. PubMed ID: 20268371
    [No Abstract]   [Full Text] [Related]  

  • 71. [Applications of subtosan-delay].
    PELLERAT J; MARAL R; MURAT
    J Med Lyon; 1947 Sep; 28(664):641-58. PubMed ID: 18900434
    [No Abstract]   [Full Text] [Related]  

  • 72. [A SIMPLE METHOD FOR MEASURING THE RELATIVE ONCOTIC EFFECTIVENESS OF COLLOIDAL PLASMA SUBSTITUTE SOLUTIONS].
    NITSCHMANN H; GYGAX HR
    Pathol Microbiol (Basel); 1964; 27():548-57. PubMed ID: 14178193
    [No Abstract]   [Full Text] [Related]  

  • 73. Periston and periston-N in the prevention of reformation of peritoneal adhesions in monkeys.
    Kapur BM; Sarangee RK; Ananthakrishnan N
    Indian J Med Res; 1976 Jun; 64(6):903-8. PubMed ID: 824201
    [No Abstract]   [Full Text] [Related]  

  • 74. [Some data on polyvinylpyrrolidone--a synthetic highly molecular compound. (Review of the literature)].
    TRUNIN MA
    Tr Leningr Sanitarnogig Med Inst; 1960; 59(Suppl)():39-42. PubMed ID: 13922711
    [No Abstract]   [Full Text] [Related]  

  • 75. A colorimetric method for the estimation of polyvinylpyrrolidone (PVP) in whole blood, plasma, and urine.
    CHINARD FP
    J Lab Clin Med; 1952 Apr; 39(4):666-72. PubMed ID: 14917932
    [No Abstract]   [Full Text] [Related]  

  • 76. [Physico-chemical studies of preparations of the synthetic blood subtitute polyvinylpyrrolidone of different therapeutic actions].
    Vasil'ev PS; Suzdaleva VS; Giul'badamova NM; Kiseleva AA
    Probl Gematol Pereliv Krovi; 1967 Oct; 12(10):28-33. PubMed ID: 5619356
    [No Abstract]   [Full Text] [Related]  

  • 77. [ON SOME EVALUATION CRITERIA FOR WHOLE BLOOD, HOMOLOGOUS PLASMA, PHYSIOLOGICAL SALT SOLUTION, PERISTON-N AND PLASMODEX. I. ESTABLISHING BLOOD PRESSURE VALUES AND THE "BLEEDING VOLUME INDEX"].
    TAMAS L; LAMI G; PETHES G
    Acta Vet Acad Sci Hung; 1965; 15():117-27. PubMed ID: 14263914
    [No Abstract]   [Full Text] [Related]  

  • 78. [The use of periston N in the detoxication of the serum and body cells, and its clinical significance].
    SCHUBERT R
    Dtsch Med Wochenschr; 1951 Nov; 76(47):1487-92. PubMed ID: 14906058
    [No Abstract]   [Full Text] [Related]  

  • 79. Polyvinylpyrrolidone: the electromigration characteristics of the blood plasma expander.
    McDONALD HJ; SPITZER RH
    Circ Res; 1953 Sep; 1(5):396-404. PubMed ID: 13082680
    [No Abstract]   [Full Text] [Related]  

  • 80. [Determination of polyvinylpyrrolidone in water and in plasma].
    DISCOMBE C; CREIG HB
    Ann Biol Clin (Paris); 1954; 12(7-9):415-8. PubMed ID: 13218346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.